PALLEIKO BENJAMIN L (CFO and Secretary) sold 2.6% of their position (10.94K shares) of KALVISTA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $147.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/26/2025ACC: 0001366244-25-000006
Officer· CFO and Secretary
Since Sep 2018
-10.94K
Net shares
Net seller
$147.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
23.25K acquired · 34.19K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+23.25K
Price / share
—
Trade value
—
% of position
5.8%
11/21/2025
403.88K→427.13K
Common Stock
Direct
Shares
−10.94K
Price / share
$13.45
Trade value
$147.15K
% of position
2.6%
11/24/2025
427.13K→416.19K
Total
Net shares
+12.31K
Net value
-$147.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/21/2025 | M · Option Exercise | +23.25K | — | — | 5.8% | 403.88K | 427.13K |
| Common Stock Direct | 11/24/2025 | S · Sale | −10.94K | $13.45 | $147.15K | 2.6% | 427.13K | 416.19K |
| Total | +12.31K | -$147.15K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
23.25K shares
Shares
−23.25K
Strike price
Held after
302.25K
Exercisable
—
11/21/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock23.25K shares | 11/21/2025 | M · Option Exercise | −23.25K | — | 302.25K |